Axalta Coating Systems

AXTA on NYSE. Axalta sells coatings to car makers, repair shops, and industrial customers. Market value $7.0bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.

Should I look at this?

Worth a closer look

Read what could go wrong

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to June 2026
7.1%high

For every $100 of what the whole company costs, it produced $7.08 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
past 12 months to June 2026
13.9×fair

You pay 13.9 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to December 2025
10.3%five-year median

Each dollar kept in the business earns 10 cents a year. Above 10 is good.

Quality score: 85 of 100. Price score: 90 of 100. Our list needs 70 on quality and 60 on price.

$32.68 a share, 31% above its 1-year low

Over the past year the price has ranged from $24.94 to $38.61.

Pays no dividend

Prices from Monday’s close (5 October).

Five years of cash, in billions

0.4
0.1
0.4
0.4
0.5
0.5
2021202220232024202512 monthsto Jun '26
Revenue
$4.4bn$4.9bn$5.2bn$5.3bn$5.1bn
Operating margin
10.5%8.7%11.3%13.4%14.4%
Debt to equity
2.572.552.031.791.36
Shares outstanding
0.22bn0.22bn0.22bn0.21bn0.21bn

Health checks

  • Free cash flow positive5 of 5 years
  • Accounting looks honest (Beneish)Nothing unusual
  • Financial strength (Piotroski)7 of 8 checks we could run
  • Profit backed by cash (accruals)Yes
  • Debt1.36× equity
  • Revenue growth, five yearsSlow, 6.5% a year
  • Buying back its own sharesYes, 3% fewer since 2021

The quarter to June 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $1.3 billion last quarter, about the same as a year ago.
  • Profit: $89 million, down 18% on a year ago.
  • It keeps 13 cents of each $1 of sales as operating profit, down from 14 cents a year earlier.
  • Spare cash over the past 12 months: $495 million, up from $413 million.
  • 2% fewer shares than a year ago. Each share owns a bit more of the company.
  • Debt is $2.4 billion more than cash, down from $2.8 billion a year ago.
  • Sales grew on a year ago in 1 of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
September 2024$1.3bn
December 2024$1.3bn
March 2025$1.3bn
June 2025$1.3bn
September 2025$1.3bn
December 2025$1.3bn
March 2026$1.3bn
June 2026$1.3bn
Profit by quarter
Profit by quarter
Quarter toAmount
September 2024$101m
December 2024$137m
March 2025$99m
June 2025$109m
September 2025$110m
December 2025$60m
March 2026$90m
June 2026$89m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
n/a
Last annual report (10-K)
13 February 2026
Next quarterly (estimated, 10-Q)
28 October 2026

Who owns it

9 long-term investors we follow own it, up from 7 last quarter. 361 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

4 investors own more than 5%.

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

No insider bought or sold on the open market in the last 12 months.

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 13 Feb 2026, plus the 10-Q filed 29 Jul 2026 and 7 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

Cheap for a reason is the question the numbers cannot answer.

Whether the price already reflects the risks is what the deep dive is for.

What changed in the risks this year

Companies must list what could hurt them each year. These are the parts that changed since last year’s report.

  • The Merger Agreement contains provisions that limit the Company’s ability to pursue alternatives to the Merger.

    Could happen
    Under the Merger Agreement, the Company is subject to certain restrictions on its ability to solicit alternative business combination proposals from third parties, engage in discussion or negotiations with respect to such proposals or provide information in connection with such proposals, subject to certain customary exceptions. Further, other than in response to a superior proposal or an intervening event, the Board may not withdraw or modify its recommendation to the Company’s shareholders in favor of the adoption of the Merger Agreement, and AkzoNobel generally has a right to match any competing business combination proposals that may be made. The Company may terminate the Merger Agreement and enter into an agreement providing for a superior proposal only if specified conditions have been satisfied, and such a termination would result in the Company being required to pay AkzoNobel a termination fee equal to €150 million. If the Merger Agreement is terminated and the Company determines to seek another business combination, the Company may not be able to negotiate a transaction with another party on terms comparable to, or better than, the terms of the Merger. While the Company believes these provisions and agreements are reasonable and customary and are not preclusive of other offers, these provisions could discourage a third party that may have an interest in entering into a strategic transaction with the Company from proposing such a strategic transaction, even if such third party were prepared to pay consideration with a higher value than the Merger Consideration (as defined below).
    Read more
  • Failure to consummate the Merger could negatively impact the share price and the future business and financial results of the Company.

    Could happen
    • The Merger Agreement restricts the Company, without AkzoNobel’s consent and subject to certain exceptions, from taking certain specified actions during the pendency of the Merger. These restrictions may prevent the Company from pursuing otherwise attractive business opportunities, entering into contracts, incurring capital expenditures to grow its business and making other changes to its business; and • If the Merger Agreement is terminated in certain circumstances, the Company may be required to pay a termination fee of €150 million to AkzoNobel.
    Read more
  • The Merger Agreement may be terminated in accordance with its terms and the Merger may not be completed.

    Could happen
    Approval by the Company’s shareholders is one such Closing Condition. A proxy contest or activist campaign related to the Merger could reduce the likelihood that we obtain shareholder approval for the Merger, demand extensive management attention and require that we incur additional costs to respond to the proxy contest or activist campaign, and, if successful, prevent the Merger from being completed.
    Read more
  • Risks Related to the Proposed Merger with Akzo Nobel N.V.

    Could happen
    • After the Merger, our shareholders will have a significantly lower ownership and voting interest in the Combined Company than they currently have in the Company.
  • While the Merger is pending, the Company will be subject to business uncertainties which could adversely affect the Company’s business, results of operations, financial condition and cash flows.

    Could happen
    Parties with which the Company does business may experience uncertainty associated with the Merger, including with respect to current or future business relationships with the Company. The Company’s business relationships may be subject to disruption as customers and suppliers may attempt to negotiate changes in existing business relationships or consider entering into business relationships with parties other than the Company. These disruptions could have an adverse effect on the businesses, financial condition, results of operations or prospects of the Company, including an adverse effect on the anticipated benefits of the Merger, which may be exacerbated by a delay in completion of the Merger or termination of the Merger Agreement. Additionally, certain contracts entered into by the Company contain change in control, anti-assignment, or certain other provisions that may be triggered as a result of the Merger. If the counterparties to these agreements do not consent to the Merger, the counterparties may have the ability to exercise certain rights (including termination rights), resulting in the Combined Company incurring liabilities as a consequence of breaching such agreements, or causing the Combined Company to lose the benefit of such agreements or incur costs in seeking replacement agreements.
    Read more

Read it in the annual report

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.